Guardian Capital Advisors LP Merck & Co., Inc. Transaction History

Guardian Capital Advisors LP

$967 Million
Q3 2024

A detailed history of Guardian Capital Advisors LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Guardian Capital Advisors LP holds 2,795 shares of MRK stock, worth $279,667. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,795

Previous 2,795 -0.0%

Holding current value

$279,667

Previous $346,000 8.38%

% of portfolio

0.03%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $2,599 - $2,792	21 Added 0.76%	2,795 $346,000
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $56,620 - $65,975	500 Added 21.99%	2,774 $366,000
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $2,404 - $2,616	24 Added 1.07%	2,274 $247,000
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $102,950 - $114,330	-1,000 Reduced 30.77%	2,250 $231,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $2,779 - $3,101	-27 Reduced 0.82%	3,250 $345,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $319,349 - $361,998	-3,825 Reduced 53.86%	3,277 $308,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $9,482 - $10,629	-129 Reduced 1.78%	7,102 $608,000
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $15,178 - $19,013	-210 Reduced 2.82%	7,231 $587,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $29,818 - $32,793	-416 Reduced 5.29%	7,441 $618,000
Q2 2021 Aug 17, 2021	SELL	$70.31 - $77.77 $11,601 - $12,832	-165 Reduced 2.06%	7,857 $618,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $14,116 - $16,627	205 Added 2.62%	8,022 $613,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $8,612 - $9,558	-120 Reduced 1.51%	7,817 $634,000
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $13,172 - $14,931	180 Added 2.32%	7,937 $639,000
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $352 - $400	5 Added 0.06%	7,757 $441,000
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $7,223 - $10,011	114 Added 1.49%	7,752 $402,000
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $1,551 - $1,750	-20 Reduced 0.26%	7,638 $687,000
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $17,118 - $18,659	225 Added 3.03%	7,658 $625,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $49,237 - $57,520	705 Added 10.48%	7,433 $645,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $60,882 - $69,440	875 Added 14.95%	6,728 $492,000
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $4,893 - $5,678	75 Added 1.3%	5,853 $429,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $2,596 - $3,052	45 Added 0.78%	5,778 $418,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $11,690 - $13,735	230 Added 4.18%	5,733 $359,000
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $15,033 - $17,472	295 Added 5.66%	5,503 $315,000
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $268,836 - $321,021	5,208	5,208 $319,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Account

Guardian Capital Advisors LP Merck & Co., Inc. Transaction History